Virtu Financial LLC Bio Cardia, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 20, 2024	SELL	$0.38 - $0.68 $10,372 - $18,560	-27,295 Reduced 66.01%	14,053 $6,000
Q4 2023 Feb 26, 2024	BUY	$0.37 - $1.07 $15,298 - $44,242	41,348 New	41,348 $27,000
Q1 2022 May 17, 2022	SELL	$21.3 - $39.0 $1.2 Million - $2.2 Million	-56,419 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$25.65 - $46.05 $1.45 Million - $2.6 Million	56,419 New	56,419 $109,000
Q3 2021 Nov 12, 2021	SELL	$42.6 - $58.65 $1.42 Million - $1.95 Million	-33,264 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$48.9 - $74.85 $1.63 Million - $2.49 Million	33,264 New	33,264 $132,000

Ticker BCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,758,200
Market Cap $39.8M
Description
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary di...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.